AI assistant
Barramundi Limited — Director's Dealing 2020
Mar 30, 2020
66172_rns_2020-03-30_826d2266-f583-4258-a467-3ff4187de040.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [98 x 28] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited;and | ||
|---|---|---|
| Name of listed issuer: | Barramundi Limited | |
| Date this disclosure made: | 30-Mar-20 | |
| Date of last disclosure: | 20-Dec-19 | |
| Director or senior managergiving disclosure | ||
| Full name(s): | RichardAndrewCoupe | |
| Name of listedissuer: | Barramundi Limited | |
| Name of related body corporate (ifapplicable): | n/a | |
| Position heldin listedissuer: | Director | |
| Summary of acquisition or disposal of relevant interest(excluding specified derivatives) | ||
| Class ofaffected quotedfinancialproducts: | Ordinary shares | |
| Nature ofthe affectedrelevantinterest(s): | Registeredholderand beneficialowner | |
| **For that relevant interest- ** | ||
| Number heldinclass before acquisitionordisposal: | 79,225 ordinary shares | |
| Number heldinclass afteracquisitionordisposal: | 81,400 ordinary shares | |
| Currentregisteredholder(s): | RichardAndrewCoupe | |
| Registeredholder(s) once transfers areregistered: | RichardAndrewCoupe | |
| Summary of acquisition or disposal of specified derivatives relevant interest(if applicable) | ||
| Type ofaffected derivative: | ||
| Class ofunderlyingfinancialproducts: | ||
| **Details of affected derivative- ** | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial | ||
| products (ifany): | ||
| Astatement as towhetherthe derivativeis cashsettled orphysically settled: | ||
| Maturity date ofthe derivative (ifany): | ||
| Expiry date ofthe derivative(ifany): | ||
| The price specifiedinthe terms ofthe derivative (ifany): | ||
| Any other details needed to understand how the amount of the consideration payable | ||
| under the derivative or the value of the derivative is affected by the value of the underlying | ||
| financialproducts: | ||
| _For that derivative,- _ | ||
| Parties to the derivative: | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant | ||
| interestinthe derivative: | ||
| Details of transactionsgiving rise to acquisition or disposal | ||
| Total numberoftransactions towhich noticerelates: | One | |
| Details of transactions requiring disclosure- | ||
| Date oftransaction: | 27-Mar-20 | |
| Nature of transaction: | 2,175 shares issued under the termsBarramundi DividendReinvestmentPlan. | |
| Name ofany otherparty orparties to the transaction(if known): | None | |
| The consideration, expressed in New Zealand dollars, paid or received for the acquisitionor disposal. If the consideration was not in cash and cannot be readily by converted into acash value, describe the consideration: | $1,148.61 (2,175 shares @ $0.5281 DRPprice) | |
| Numberof financialproducts towhichthe transaction related: | One | |
| If the issuer has a financial products trading policy that prohibits directors or senior | ||
| managers from trading during any period without written clearance (a closed period) | ||
| include the following details— | ||
| Whether relevantinterestswere acquired ordisposed ofduring a closed period: | Not during closed period | |
| Whether prior written clearance was provided to allow the acquisition or disposal toproceed during the closed period: | n/a | |
| Date ofthe prior writtenclearance (ifany): | n/a | |
| Summary of other relevant interests after acquisition or disposal: | ||
| Class ofquotedfinancialproducts: | ||
| Nature of relevantinterest: | ||
| _For that relevant interest,- _ | ||
| Number heldinclass: | ||
| Currentregisteredholder(s): |
For a derivative relevant interest,- Type of derivative: Details of derivative,- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:
==> picture [54 x 24] intentionally omitted <==
30-Mar-20